RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Zabota 2.0 (LLC Medicine)

Company

Content

Owners

+ Vladimir Olegovich Potanin

Zabota 2.0 is a Russian medical tech startup that develops a system for automating patient care, prevention and medical marketing. The company helps private clinics automate marketing and communication with patients using an array of medical data: medical histories, made diagnoses, doctors' forecasts, etc. This method of individual care significantly increases the loyalty of people and motivates them to more carefully monitor their health by re-visiting clinics, the developers say.

Zabota 2.0 was founded in 2014 by Dmitry Laptev and Vladimir Selivanov.

History

2025: T-Bank Fund bought a stake in Medicine

On July 1, 2025, it became known that the T-Investment venture fund (JSC T-Bank"") acquired a stake in the Russian technology company Medicine"." In addition, the management company ST Capital invested funds in this organization.

According to the Vedomosti newspaper, the Venture Investments 1 fund, which operates in the form of a closed mutual investment fund (ZPIF) under the management of T-Capital Management Company, received 11.22% in the authorized capital of Medicine LLC. In turn, ST Capital acquired 5.26%. The amount of transactions at the time of their execution was not disclosed.

The T-Bank Fund bought a stake in the medical company "Medicine"

The company "Medicine" is engaged in the promotion of the analytical system of communication with patients Zabota 2.0. It integrates with the organization's medical information system, analyzes patients by 86 parameters and, based on the data obtained, builds personalized communication with each person using more than 270 scenarios. The use of the Zabota 2.0 platform is said to increase the clinic's revenue by 20-25%. The system provides full workload for doctors, as well as reduces marketing and advertising costs. At the same time higher efficiency of medical institution operation is achieved through increase of conversions at all stages of patient's path. Clinic administrators can save up to three hours of working time per day. The average payback period for Zabota 2.0, according to the developers, is 3-4 months.

It is reported that the funds received from T-Investments and ST Capital will allow the Zabota 2.0 project to expand the development team, make the system more accessible when implemented, as well as move to predictive analysis and increase hyperpersonalization by introducing artificial intelligence technologies.[1]

2021: Attracting investment from Sergey Solonin

On April 20, 2021, it became known about the investments of the co-founder of the QiwiSergey Solonin group in Zabota 2.0. The financial terms of the transaction were not disclosed.

According to the Unified State Register of Legal Entities, the founders of the startup Dmitry Laptev and Vladimir Selivanov own 36.25% each in Medicine LLC (legal entity Zabota 2.0). Alena Kalimullina owns 14.5%, Ruslan Kalimullin - 9.67%. Sergey Solonin received 3.33% in the startup.

By April 2021, about 700 clinics were connected to the Zabota 2.0 platform, in 2021 the company plans to increase their number to 3 thousand.

Sergey Solonin invested in medical tech startup Zabota 2.0
File:Aquote1.png
A distinctive feature of millennials is that they trust ratings and real reviews more, absolutely do not believe in brands and are fully involved in digital technologies, "said Dmitry Laptev, co-founder of Zabota 2.0, commenting on the news of Sergey Solonin's investments.
File:Aquote2.png

According to Solonin, the future of private clinics depends on the effective application of information technology in the processing of medical data that takes into account the features of the millennial generation. Zabota 2.0 predicts that from 2023, more than 50% of private clinic income will depend on a generation of people born between 1980 and 2000.[2]

Notes